108 related articles for article (PubMed ID: 25707145)
21. [Immuno-analytical characteristics of PSA and derived biomarkers (total PSA, free PSA, p2PSA)].
Desbène C; Boissan M; Loric S; Lamy PJ; Piéroni L
Ann Biol Clin (Paris); 2023 Mar; 81(1):7-23. PubMed ID: 36757372
[TBL] [Abstract][Full Text] [Related]
22. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
[TBL] [Abstract][Full Text] [Related]
23. Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective study.
Abrate A; Lazzeri M; Lughezzani G; Buffi N; Bini V; Haese A; de la Taille A; McNicholas T; Redorta JP; Gadda GM; Lista G; Kinzikeeva E; Fossati N; Larcher A; Dell'Oglio P; Mistretta F; Freschi M; Guazzoni G
BJU Int; 2015 Apr; 115(4):537-45. PubMed ID: 25130593
[TBL] [Abstract][Full Text] [Related]
24. Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer.
Mikolajczyk SD; Catalona WJ; Evans CL; Linton HJ; Millar LS; Marker KM; Katir D; Amirkhan A; Rittenhouse HG
Clin Chem; 2004 Jun; 50(6):1017-25. PubMed ID: 15054080
[TBL] [Abstract][Full Text] [Related]
25. Re: Clinical performance of serum isoform (-2)proPSA (p2PSA) and its derivatives, namely %p2PSA and PHI (Prostate Health Index) in men younger than 60 years of age: results from a multicentric European study.
Taneja SS
J Urol; 2014 Aug; 192(2):421. PubMed ID: 25034991
[No Abstract] [Full Text] [Related]
26. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
27. Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.
Jansen FH; Roobol M; Jenster G; Schröder FH; Bangma CH
Eur Urol; 2009 Mar; 55(3):563-74. PubMed ID: 19058905
[TBL] [Abstract][Full Text] [Related]
28. Next-generation prostate-specific antigen test: precursor form of prostate-specific antigen.
Ito K; Fujizuka Y; Ishikura K; Cook B
Int J Clin Oncol; 2014 Oct; 19(5):782-92. PubMed ID: 25135462
[TBL] [Abstract][Full Text] [Related]
29. The impact of baseline [-2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort.
Hirama H; Sugimoto M; Ito K; Shiraishi T; Kakehi Y
J Cancer Res Clin Oncol; 2014 Feb; 140(2):257-63. PubMed ID: 24352745
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic Performance of %[-2]proPSA and Prostate Health Index for Prostate Cancer: Prospective, Multi-institutional Study.
Park H; Lee SW; Song G; Kang TW; Jung JH; Chung HC; Kim SJ; Park CH; Park JY; Shin TY; Suh IB; Kim JH
J Korean Med Sci; 2018 Mar; 33(11):e94. PubMed ID: 29495138
[TBL] [Abstract][Full Text] [Related]
31. A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases.
Stephan C; Kahrs AM; Cammann H; Lein M; Schrader M; Deger S; Miller K; Jung K
Prostate; 2009 Feb; 69(2):198-207. PubMed ID: 18942119
[TBL] [Abstract][Full Text] [Related]
32. Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
Steuber T; Vickers AJ; Haese A; Becker C; Pettersson K; Chun FK; Kattan MW; Eastham JA; Scardino PT; Huland H; Lilja H
Int J Cancer; 2006 Mar; 118(5):1234-40. PubMed ID: 16152616
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml.
Khan MA; Partin AW; Rittenhouse HG; Mikolajczyk SD; Sokoll LJ; Chan DW; Veltri RW
J Urol; 2003 Sep; 170(3):723-6. PubMed ID: 12913682
[TBL] [Abstract][Full Text] [Related]
34. p2PSA but not total and free PSA increases after myocardial infarction: results of a preliminary investigation.
Lippi G; Aloe R; Cervellin G
Int J Cardiol; 2011 Nov; 153(1):119. PubMed ID: 21968074
[No Abstract] [Full Text] [Related]
35. Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography.
Yu GP; Na R; Ye DW; Qi J; Liu F; Chen HT; Wu YS; Zhang GM; Sun JL; Zhu Y; Huang LQ; Ren SC; Jiang DK; Zheng SL; Jiang HW; Sun YH; Ding Q; Xu J
Asian J Androl; 2016; 18(4):633-8. PubMed ID: 26975483
[TBL] [Abstract][Full Text] [Related]
36. A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer.
Mikolajczyk SD; Marker KM; Millar LS; Kumar A; Saedi MS; Payne JK; Evans CL; Gasior CL; Linton HJ; Carpenter P; Rittenhouse HG
Cancer Res; 2001 Sep; 61(18):6958-63. PubMed ID: 11559576
[TBL] [Abstract][Full Text] [Related]
37. Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.
Jansen FH; van Schaik RH; Kurstjens J; Horninger W; Klocker H; Bektic J; Wildhagen MF; Roobol MJ; Bangma CH; Bartsch G
Eur Urol; 2010 Jun; 57(6):921-7. PubMed ID: 20189711
[TBL] [Abstract][Full Text] [Related]
38. PSA and other tissue kallikreins for prostate cancer detection.
Stephan C; Jung K; Lein M; Diamandis EP
Eur J Cancer; 2007 Sep; 43(13):1918-26. PubMed ID: 17689069
[TBL] [Abstract][Full Text] [Related]
39. Effect of body mass index on the performance characteristics of PSA-related markers to detect prostate cancer.
Zhu Y; Han CT; Zhang GM; Liu F; Ding Q; Xu JF; Vidal AC; Freedland SJ; Ng CF; Ye DW
Sci Rep; 2016 Jan; 6():19034. PubMed ID: 26754552
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of proprostate-specific antigen in the diagnosis of prostate cancer.
Filella X; Alcover J; Molina R; Luque P; Corral JM; Augé JM; Coca F
Anticancer Res; 2007; 27(1B):607-10. PubMed ID: 17348449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
